Medicine
Doxycycline 150 mg tablet
Doxycycline 150 mg tablet is a generic prescription medicine for oral use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F)…
Key facts
- Active ingredient (INN)
- Doxycycline
- Brand
- Sold under the generic name
- Strength
- 150 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 60 tablets, 1000 tablets, 100 tablets and 19 more
- Manufacturers
- Alembic PharmaceuticalsIndiaAvet PharmaceuticalsIndiaSun Pharmaceutical IndustriesIndiaZydus LifesciencesIndiaAjanta PharmaIndiaLupinIndiaStrides PharmaIndiaLannettChartwell RX
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F). Protect from light and moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A01AB22 Doxycycline
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 25 August 2008
- Identifiers
- RxCUI 1649425, 1650446, 1649429 +4DailyMed set ID cec4368f-2852-443d-9d6f-7ba95807021b, 8224b9c5-5c4b-4dda-bc58-47b6604c2884, f234f419-42da-4a6d-82c6-92106cd77c67 +8NDC 62332-388, 63304-173, 68180-654 +8Application ANDA211744, ANDA065356, ANDA208818 +6
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 60 tablet, film coated in 1 bottle | 46708-388-60 | Alembic PharmaceuticalsIndia | 30 June 2020 |
| 1000 tablet, film coated in 1 bottle | 46708-388-91 | Alembic PharmaceuticalsIndia | 30 June 2020 |
| 60 tablet, film coated in 1 bottle | 62332-388-60 | Alembic PharmaceuticalsIndia | 30 June 2020 |
| 1000 tablet, film coated in 1 bottle | 62332-388-91 | Alembic PharmaceuticalsIndia | 30 June 2020 |
| 100 tablet, film coated in 1 bottle | 70710-1124-1 | Zydus LifesciencesIndia | 11 January 2018 |
| 30 tablet, film coated in 1 bottle | 70710-1124-3 | Zydus LifesciencesIndia | 11 January 2018 |
| 100 tablet, film coated in 1 bottle | 70771-1009-1 | Zydus LifesciencesIndia | 11 January 2018 |
| 30 tablet, film coated in 1 bottle | 70771-1009-3 | Zydus LifesciencesIndia | 11 January 2018 |
| 60 tablet in 1 bottle | 27241-154-02 | Ajanta PharmaIndia | 1 June 2020 |
| 30 tablet in 1 bottle | 23155-136-03 | Avet PharmaceuticalsIndia | 1 May 2012 |
| 500 tablet in 1 bottle | 23155-136-05 | Avet PharmaceuticalsIndia | 1 May 2012 |
| 10 tablet in 1 blister pack | 23155-136-11 | Avet PharmaceuticalsIndia | 1 May 2012 |
| 30 tablet in 1 carton | 23155-136-30 | Avet PharmaceuticalsIndia | 1 May 2012 |
| 60 tablet, coated in 1 bottle | 68180-654-07 | LupinIndia | 30 October 2017 |
| 30 tablet in 1 bottle | 64380-927-01 | Strides PharmaIndia | 24 September 2026 |
| 10 tablet, film coated in 1 bottle | 63304-173-03 | Sun Pharmaceutical IndustriesIndia | 6 August 2018 |
| 1000 tablet, film coated in 1 bottle | 63304-173-10 | Sun Pharmaceutical IndustriesIndia | 6 August 2018 |
| 30 tablet, film coated in 1 bottle | 63304-173-30 | Sun Pharmaceutical IndustriesIndia | 6 August 2018 |
| 1 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 63304-173-69 | Sun Pharmaceutical IndustriesIndia | 6 August 2018 |
| 20 tablet, film coated in 1 bottle | 62135-908-20 | Chartwell RX | 26 March 2025 |
| 100 tablet, film coated in 1 bottle, plastic | 0527-1537-01 | Lannett | 25 August 2008 |
| 30 tablet, film coated in 1 bottle, plastic | 0527-1537-30 | Lannett | 25 August 2008 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 5 December 1967 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Doxycycline
Clinical summary
Doxycycline is a tetracycline-class drug indicated for the treatment of infections, among other approved uses. It is available as capsules, tablets and powder for injection for oral and intravenous use. MedsAcross supplies Doxycycline for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DoxycyclineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Doxycycline prescribing information (Wellhouse Pharma) · U.S. National Library of Medicine, DailyMed
Need Doxycycline 150 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.